retatrutide cardiovascular effects Retatrutide—A Game Changer in Obesity Pharmacotherapy 🔬 Retatrutide — why cardiology

And its changed SO many aspects of his life including his sex life with his wife Bunnie XO

Cell Endocrinol

Oral GLP-1 Approaches Commercial Inflection by 2028 GLP-1 Weight Loss Drug Market Revenue Share, CAGR, and Primary Drivers by Route 2026 Subcutaneous injectable administration commands 81.7% GLP-1 market revenue share in 2026 as the weekly autoinjector format delivers clinical efficacy, dose consistency, and patient convenience superior to daily injectable alternatives

Unfortunately, theres no one set answer

In clinical trials for weight management, tirzepatide produced average weight loss of 20-25% of body weight, roughly double what semaglutide achieves at comparable endpoints